This meta-analysis of 30 randomized controlled trials investigated the impact of testosterone replacement therapy (TRT) on cardiovascular outcomes. It found that TRT did not significantly affect cardiovascular mortality but improved cholesterol levels and reduced systolic blood pressure. However, concerns about long-term cardiovascular risks persist. Providers should monitor cardiovascular health during
